Klazien Matter-Walstra

11. Juni 2016

Newest publication

Palbociclib as a first-line treatment in oestrogen receptor-positive, HER2-negative, advanced breast cancer not cost-effective with current pricing: a health economic analysis of the Swiss Group for Clinical Cancer Research (SAKK).

Matter-Walstra K, Ruhstaller T, Klingbiel D, Schwenkglenks M, Dedes KJ.

Breast Cancer Res Treat. 2016 Jun 8. [Epub ahead of print]

Tags: Arbeit

Kommentar schreiben

Kommentare: 0

Sa

27

Jan

2024

Publication

Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.

Daniel Krüerke , Marianne Schenker, Klazien Matter-Walstra

Sa

27

Jan

2024

Croatia-Montenegro sailing

Sa

27

Jan

2024

Newest Art

See some of my newest works

Mi

10

Mai

2023

Croatia Mai-June 2023

Sailing in Croatia Mai-June 2023

Di

11

Okt

2022

Croatia 2022

Fr

18

Jun

2021

Sailing 2021

Sailing trip Italy Greece

mehr lesen